Format

Send to

Choose Destination
Clin Exp Otorhinolaryngol. 2011 Mar;4(1):1-10. doi: 10.3342/ceo.2011.4.1.1. Epub 2011 Mar 17.

Current management of advanced resectable oral cavity squamous cell carcinoma.

Author information

1
Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Abstract

The oral cavity is the most common site of head and neck squamous cell carcinoma, a disease which results in significant morbidity and mortality worldwide. Though the primary modality of treatment for patients with oral cavity cancer remains surgical resection, many patients present with advanced disease and are thus treated using a multi-disciplinary approach. Patients with extracapsular spread of lymphatic metastasis and surgical margins that remain positive have been found to be at high risk for local-regional recurrence and death from disease, and are most often recommended to receive both post-operative radiation as well as systemic chemotherapy. The basis for this approach, as well as scientific developments that underly future trials of novels treatments for patients with high-risk oral cavity cancer are reviewed.

KEYWORDS:

Chemotherapy; Head and neck neoplasms; Oral cancer; Radiotherapy; Surgery; Treatment

Supplemental Content

Full text links

Icon for Korean Society of Otorhinolaryngology-Head and Neck Surgery Icon for PubMed Central
Loading ...
Support Center